Boston Scientific (BSX) Long-Term Debt Issuances (2010 - 2025)

Boston Scientific has disclosed Long-Term Debt Issuances across 14 years of filings, most recently posting $1.6 billion for Q1 2025.

• Long-Term Debt Issuances for Q1 2025 came in at $1.6 billion, down 27.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 billion (down 27.37% YoY), and the FY2025 annual result was $1.6 billion, down 27.37% from the prior year.
• Long-Term Debt Issuances came in at $1.6 billion for Q1 2025 at Boston Scientific, down from $2.1 billion in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $3.3 billion in Q1 2022 to a low of -$1.0 million in Q2 2022.
• The 3-year median for Long-Term Debt Issuances is $1.9 billion (2024), against an average of $1.7 billion.
• Peak annual rise in Long-Term Debt Issuances reached 27.37% in 2025, while the deepest fall reached 27.37% in 2025.
• Boston Scientific's Long-Term Debt Issuances stood at -$1.0 million in 2022, then soared by 214600.0% to $2.1 billion in 2024, then slipped by 27.37% to $1.6 billion in 2025.
• The last three Long-Term Debt Issuances figures came in at $1.6 billion (Q1 2025), $2.1 billion (Q1 2024), and -$1.0 million (Q2 2022), per Business Quant data.